US Patent 8124104 Norovirus and sapovirus antigens
Patent 8124104 was granted and assigned to Novartis on February, 2012 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 8124104 Norovirus and sapovirus antigens
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
